What is the serial number for IMPLANTABLE SYSTEM FOR REMODULIN (TREPROSTINIL) INJECTION?

The USPTO serial number for IMPLANTABLE SYSTEM FOR REMODULIN (TREPROSTINIL) INJECTION is 88345763.

What is the registration number for IMPLANTABLE SYSTEM FOR REMODULIN (TREPROSTINIL) INJECTION?

IMPLANTABLE SYSTEM FOR REMODULIN (TREPROSTINIL) INJECTION is registered under USPTO registration number 0.

IMP

USPTO Trademark Record

ABANDONED

IMPLANTABLE SYSTEM FOR REMODULIN (TREPROSTINIL) INJECTION

Q: Who owns the IMPLANTABLE SYSTEM FOR REMODULIN (TREPROSTINIL) INJECTION trademark?

The IMPLANTABLE SYSTEM FOR REMODULIN (TREPROSTINIL) INJECTION trademark is owned by United Therapeutics Corporation.

Q: What class is the IMPLANTABLE SYSTEM FOR REMODULIN (TREPROSTINIL) INJECTION trademark registered in?

The IMPLANTABLE SYSTEM FOR REMODULIN (TREPROSTINIL) INJECTION trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

SN 88345763·Reg 0·Filed Mar 19, 2019

Owner United Therapeutics Corporation

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

IMPLANTABLE SYSTEM FOR REMODULIN (TREPROSTINIL) INJECTION (Serial No. 88345763), Registration No. 0, is a abandoned US trademark filed on Mar 19, 2019 by United Therapeutics Corporation. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

Mark Intelligence

IMPLANTABLE SYSTEM FOR REMODULIN (TREPROSTINIL) INJECTION (Reg. #0) is an abandoned US trademark that was filed in 2019 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 010 (Surgical, medical, dental & veterinary apparatus) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 19, 2019

SERIAL

88345763

REG#

Owner

Applicant

United Therapeutics Corporation

Entity

Corporation

State

Address

1040 Spring Street, Silver Spring, MD, 20910

Country

Attorney

NameNorm J. Rich

Law firm

Norm J. Rich FOLEY & LARDNER LLP

Docket

080618-1868

Address

3000 K STREET, N.W., SIXTH FLOOR, WASHINGTON, DC 20007, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateMar 19, 2019

Serial Number88345763

Registration No.0

Status DateOct 18, 2021

Published for OppositionJul 23, 2019

Mark TypeDesign with words

Attorney Docket080618-1868

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 010Surgical, medical, dental & veterinary apparatus

US codes: 026, 039, 044

Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

28 events

ABANDONMENT - NO USE STATEMENT FILED

Oct 18, 2021

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 18, 2021

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 18, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 3 GRANTED

Mar 16, 2021

SOU EXTENSION 3 GRANTED

SOU EXTENSION 3 FILED

Mar 16, 2021

SOU EXTENSION 3 FILED

SOU TEAS EXTENSION RECEIVED

Mar 16, 2021

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 12, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 10, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Sep 10, 2020

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Sep 10, 2020

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 13, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 FILED

Mar 11, 2020

SOU EXTENSION 1 FILED

SOU TEAS EXTENSION RECEIVED

Mar 11, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 GRANTED

Mar 11, 2020

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 17, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jul 23, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 23, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 03, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Jun 17, 2019

ASSIGNED TO LIE

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jun 03, 2019

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 03, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINER'S AMENDMENT ENTERED

Jun 03, 2019

EXAMINER'S AMENDMENT ENTERED

EXAMINERS AMENDMENT -WRITTEN

Jun 03, 2019

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jun 03, 2019

EXAMINERS AMENDMENT E-MAILED

ASSIGNED TO EXAMINER

May 30, 2019

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Apr 06, 2019

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 05, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 22, 2019

NEW APPLICATION ENTERED

IMPLANTABLE SYSTEM FOR REMODULIN (TREPROSTINIL) INJECTION

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by United Therapeutics Corporation

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Norm J. Rich

Resources

Company